Cleerly LABS vs Implicity ILR ECG Analyzer
AI Verdict
Choose Cleerly LABS if…
Choose Cleerly LABS if your primary goal is to obtain a detailed, non-invasive assessment of coronary artery disease through CCTA. This tool is ideal for quantifying and characterizing atherosclerosis, detecting stenosis, and assessing ischemia to inform personalized heart disease management and track disease progression over time.
View Cleerly LABS →Choose Implicity ILR ECG Analyzer if…
Choose Implicity ILR ECG Analyzer if you require an AI-powered solution for efficient remote monitoring of cardiac implantable electronic devices (CIEDs) and implantable loop recorders (ILRs). This platform is best suited for reducing false positive alerts, centralizing device data, and optimizing clinical workflows for arrhythmia detection and patient connectivity management.
View Implicity ILR ECG Analyzer →Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Quick Comparison
| Feature | Cleerly LABS | Implicity ILR ECG Analyzer |
|---|---|---|
| Pricing | Varies | Contact vendor for pricing information. |
| Deployment | Cloud, On-premise | Cloud-based / SaaS |
| BAA Available | Yes AI-estimated | Yes AI-estimated |
| FDA Status | Cleared AI-estimated | Cleared AI-estimated |
| HIPAA | Yes AI-estimated | Yes AI-estimated |
Head-to-Head
AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.
Usability
Implicity ILR ECG AnalyzerImplicity ILR ECG Analyzer (Tool B) emphasizes smart workflow automation, unified device data, and a dynamic billing engine, which directly addresses the operational efficiency and ease of use for managing high volumes of remote cardiac monitoring data. Cleerly LABS (Tool A) focuses on web-based visualization and PACS/RIS/EHR integration, but Tool B's features suggest a more comprehensive approach to streamlining daily clinical and administrative tasks for its users.
Clinical Value
Implicity ILR ECG AnalyzerImplicity ILR ECG Analyzer (Tool B) provides specific, quantifiable clinical benefits, such as reducing false positives by 79% for Medtronic ILRs while maintaining 99% sensitivity and an 85% decrease in unnecessary AF alerts. These metrics directly translate to improved clinical efficiency, reduced alert fatigue, and more focused care. Cleerly LABS (Tool A) offers comprehensive plaque assessment and stenosis detection, which is valuable for personalized heart disease management, but Tool B's impact on workflow and alert accuracy is more explicitly defined.
Pricing & Value
Cleerly LABSCleerly LABS (Tool A) provides transparent pricing details, including a retail price and a discounted offer, allowing potential users to evaluate the cost upfront. Implicity ILR ECG Analyzer (Tool B) requires contacting them for pricing, which makes it difficult to assess its value proposition without further inquiry.
Enterprise Readiness
Implicity ILR ECG AnalyzerBoth tools are FDA-cleared, HIPAA compliant, and offer BAAs, demonstrating strong foundational readiness. However, Implicity ILR ECG Analyzer (Tool B) explicitly highlights features like unified device data, smart workflow automation, and a dynamic billing engine that achieves 90%+ billing compliance, indicating a more comprehensive suite of features designed to integrate seamlessly and manage the operational and financial complexities of a large healthcare enterprise for remote monitoring.
Innovation
Cleerly LABSCleerly LABS (Tool A) focuses on creating a 'new standard of care' by providing AI-powered, comprehensive analysis of CCTA to detect, quantify, and characterize atherosclerosis and stenosis, which represents a significant advancement in non-invasive cardiovascular diagnostics. Implicity ILR ECG Analyzer (Tool B) innovates by applying AI to optimize existing remote monitoring workflows and reduce alert fatigue, which is valuable but less of a paradigm shift in diagnostic capability compared to Tool A's approach to plaque characterization.
Support & Docs
Implicity ILR ECG AnalyzerImplicity (Tool B) explicitly details a dedicated Customer Success team that provides comprehensive support, including tailored training sessions for various staff profiles, ongoing assistance, best practice sharing, and regular activity reviews. Cleerly (Tool A) offers customer support during business hours and provides a contact form for technical support. Implicity's described support structure appears more hands-on and proactive for enterprise clients.
Feature-by-Feature
Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.
| Feature | Cleerly LABS | Implicity ILR ECG Analyzer |
|---|---|---|
| Tool Name | Cleerly LABS | Implicity ILR ECG Analyzer |
| Company | Cleerly | Implicity |
| Primary Application/Focus | Comprehensive analysis of coronary CT angiography (CCTA) to detect, quantify, and characterize atherosclerosis and stenosis. | Smart remote monitoring solutions for cardiac implantable electronic devices (CIEDs) and implantable loop recorders (ILRs), enhancing arrhythmia detection and optimizing clinical workflows. |
| Core AI Functionality | AI-powered CCTA image analysis for comprehensive coronary plaque assessment and stenosis detection. | AI-Powered ILR ECG Analyzer to reduce false positives and AI-Driven Alert Management to filter clinically relevant events. |
| Target Data Type | Coronary CT angiography (CCTA) images | ECG data from cardiac implantable electronic devices (CIEDs) and implantable loop recorders (ILRs) |
Videos
Demos, reviews, and walkthroughs featuring Cleerly LABS and Implicity ILR ECG Analyzer.
Frequently Asked Questions
More Comparisons
More matchups featuring Cleerly LABS or Implicity ILR ECG Analyzer
Backers
Who funded each tool's parent company.